IndraLab

Statements


4 | 7 17

reach
"Furthermore, a negative association between USP8 and PD-L1 was confirmed in lung squamous cancer tissues."

sparser
"There is a positive interaction between PD-L1 and USP8 in pancreatic cancer."

sparser
"The PD-1/PD-L1 inhibitory signal plays an important role in tumor immune escape and is an important target of anti-tumor immunotherapy; therefore, we further assessed whether USP8 interacts with PD-L1."

sparser
"Moreover, we observed that endogenous USP8 and endogenous PD-L1 interacted in pancreatic cancer cell lines (KPC, BxPC-3, SW1990) (Fig.  xref )."

sparser
"Furthermore, direct binding of USP8 to PD-L1 was demonstrated in vitro using a GST pull-down assay (Fig.  xref )."

sparser
"These results revealed that USP8 and PD-L1 interact positively in pancreatic cancer."

sparser
"The endogenous interaction between USP8 and PD-L1 was also confirmed by Co-IP and immunoblotting assays in DU145 and PC-3 cells (Fig. xref )."

reach
"There is a positive interaction between PD-L1 and USP8 in pancreatic cancer."

reach
"Furthermore, direct binding of USP8 to PD-L1 was demonstrated in vitro using a GST pull-down assay (Fig. 3h)."

sparser
"These results revealed that USP8 specifically interacts with PD-L1 protein and affects the expression level of PD-L1 protein but not mRNA in PCa."

sparser
"To illustrate the process of deubiquitination of PD-L1 in PDAC, Yang et al. reported that USP8 bound with PD-L1 and upregulated its expression by impairing the proteasome-mediated degradation pathway."

sparser
"First, Co-IP assay was performed, the findings of which confirmed an interaction between USP8 and PD-L1 (Fig.  xref A)."

No evidence text available

sparser
"USP8, a new PD-L1 deubiquitinase, interacts with PD-L1, thereby inhibiting its ubiquitination-dependent proteasomal degradation in pancreatic cancer."

sparser
"Mechanistically, USP8 directly interacts with PD-L1 and upregulates PD-L1 protein levels by blocking the ubiquitin-proteasome degradation pathway."

reach
"USP7, USP22, USP8, USP18, USP9X and USP5 have been demonstrated directly bind with PD-L1 to induce its deubiquitination and stabilization [60, 100–102, 143, 164, 186]."

sparser
"ChIP assay confirmed the interaction between USP8 and PD-L1 proteins."

sparser
"Moreover, USP8 interacted positively with PD-L1 and upregulated its expression by inhibiting the ubiquitination-regulated proteasome degradation pathway in pancreatic cancer."

sparser
"Additionally, research by Bai et al. demonstrated that USP8 interacts with PD-L1 in pancreatic cancer, stabilizing PD-L1 expression by inhibiting its ubiquitin-mediated proteasomal degradation."

reach
"First, Co-IP assay was performed, the findings of which confirmed an interaction between USP8 and PD-L1 (Fig. 6A)."

reach
"A direct interaction between USP8 and PD-L1 leads to the upregulation of PD-L1 expression by inhibiting ubiquitination-regulated proteasomal degradation of PD-L1 proteins in pancreatic ductal adenocar[MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]"

sparser
"Another study showed that USP8 can directly bind to PD-L1 and remove its ubiquitination modification, thereby stabilizing the protein expression level of PD-L1 and ultimately promoting the process of immune evasion in pancreatic cancer ( xref )."

reach
"Direct binding of SNHG12 to HuR, as well as binding of PD-L1 and USP8 to HuR, was predicted using RNA–protein interaction prediction (RPISeq) (http://pridb.gdcb.iastate.edu/RPISeq/, accessed on 19 June 2023) and validated by RIP assay [151]."

sparser
"USP8 binds to PD-L1, enhancing K48-linked ubiquitination and reducing K63-linked ubiquitination levels, thereby balancing the action of TRAF6 and maintaining PD-L1 stability [ xref ]."

No evidence text available

No evidence text available

No evidence text available

sparser
"A direct interaction between USP8 and PD-L1 leads to the upregulation of PD-L1 expression by inhibiting ubiquitination-regulated proteasomal degradation of PD-L1 proteins in pancreatic ductal adenocar[MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]"